Intrawound application of vancomycin changes the responsible germ in elective spine surgery without significant

B Mirzashahi1, M Chehrassan2, S M J Mortazavi1,3

  • 1Orthopedic Department of Imam Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Intrawound vancomycin did not reduce surgical site infections (SSI) in spine surgery patients. However, it did alter the types of bacteria causing infections, with Staphylococcus aureus being more prevalent in the control group.

Area of Science:

  • Neurosurgery
  • Infectious Disease
  • Clinical Trials

Background:

  • Surgical site infection (SSI) is a significant complication following spine surgery, leading to increased healthcare costs.
  • The prophylactic role of intrawound vancomycin in preventing SSIs after spine surgery remains incompletely understood.
  • This study aimed to investigate the efficacy of intrawound vancomycin in reducing SSI risk in elective spine surgery.

Purpose of the Study:

  • To determine if the application of vancomycin directly into the surgical wound reduces the incidence of surgical site infection (SSI) in patients undergoing elective spine surgery.
  • To evaluate the association between intrawound vancomycin use and the risk of developing SSI within 30 days post-operation.

Main Methods:

  • A prospective randomized controlled trial was conducted over 15 months involving patients undergoing elective spine surgery.
  • Patients were allocated into two groups: one receiving intrawound vancomycin and a control group without vancomycin.
  • The primary outcome measured was the relative risk of SSI within 30 days post-surgery.

Main Results:

  • A total of 380 patients were analyzed, with 51% receiving intrawound vancomycin.
  • The prevalence of SSI was 2.7% in the no-vancomycin group versus 5.2% in the vancomycin group.
  • Multivariable analysis identified increased levels exposed, ICU admission, obesity, and extensive instrumentation (>2 levels) as risk factors for SSI. Common pathogens differed between groups, with Staphylococcus aureus more frequent in the control group.

Conclusions:

  • Intrawound vancomycin application was not associated with a decreased risk of surgical site infection or return to the operating room for SSI in this patient cohort.
  • The use of intrawound vancomycin appeared to influence the spectrum of causative microorganisms, shifting the predominant pathogens observed.
  • Further research may be warranted to explore specific patient subgroups or alternative prophylactic strategies.